The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.

Regeneron Pharmaceuticals has collaborated with Mammoth Biosciences to develop in vivo clustered regularly interspaced short ...

Robotics company Multiply Labs has partnered with global life-sciences service provider GenScript Biotech to automate the ...

Merck has reported a significant increase in net income attributable to shareholders, reaching $4.76bn in the first quarter ...

The Series B extension proceeds will fund Phase III trial for Cerevance’s lead CNS therapy, CVN424, in patients with ...

AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn reported ...

In Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question this market’s ...

The US Food and Drug Administration (FDA) has approved Utility Therapeutics’ Pivya tablets, a new treatment for female adults ...

A Senate Committee is investigating the “outrageously high” US price tags of the blockbuster diabetes and obesity drugs.

Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate REZZAYO (rezafungin) ...

Marking another chapter in the long-running saga, J&J has deprioritised the CD388 influenza programme allowing Cidara to buy ...

Biogen has reported net income of $393.4m for the first quarter (Q1) of 2024, an increase from $387.6m in the same period a ...